Navigation Links
Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
Date:10/8/2011

PITTSBURGH, Oct. 8, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today commented on the death of Milan "Mike" Puskar, Mylan's co-founder, namesake, former chairman and CEO.

Mylan Chairman and CEO Robert J. Coury said: "We were deeply saddened by the passing of Mike Puskar, a truly one-of-a-kind individual. Mike was a pioneer in many ways and helped to create the generics industry as we know it today. Those of us who knew Mike personally will always remember him as a strong leader, thoughtful mentor, generous benefactor and faithful friend. His greatest gift to Mylan, however, was his insistence on high quality. Through this determined focus on quality, Mylan raised the bar for the entire generic pharmaceutical industry. Mike's simple and clear philosophy was, 'Do it right or don't do it at all,' and he expressed this very powerful idea in many ways over the years."

"Mike's emphasis on quality was rivaled only by his desire to meet unmet needs. His generosity in the community of Morgantown, W.Va., is legendary, and the beneficiaries of his giving are too numerous to count.

"Though Mike's formal association with Mylan ended in 2009 when he retired as the chairman of the board of directors, his powerful commitment to quality continues to touch every corner of our company, and shapes the basis of our values, unique corporate culture and strategy for the future. Mike will be deeply missed, but his legacy will live on."


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs
2. Mylan Announces XELODA® Settlement and License Agreement
3. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
4. Mylan Launches Generic Version of Uroxatral® Tablets
5. Mylan Announces U.S. PTO Intends to Reissue Two Perforomist® Patents to Dey Pharma
6. Mylan Launches First Generic Version of Entocort EC® Capsules
7. Mylan Receives Approval for Generic Version of Aricept® Tablets
8. Mylan Receives Approval for Generic Version of Effexor XR® Capsules
9. Mylan Launches Generic Version of Roxicodone® Tablets
10. Mylan Launches Generic Version of Depakote® Sprinkle Capsules
11. Mylan Launches First Generic Version of Xibrom® Ophthalmic Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
(Date:6/23/2016)... , ... June 23, 2016 , ... Representatives of CHA ... the newest member of their staff, Dr. Joshua J. Berger. As of May ... of the world-renowned facility. , Dr. Berger has received recognition for his research, his ...
Breaking Medicine News(10 mins):